Central Nervous System Therapeutic Market: By Disease (Neurovascular Diseases, Mental Health (Anxiety Disorders, Mood Disorders, Epilepsy, Psychotic Disorders, Others), Neurodegenerative Diseases (Parkinson’s Disease, Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Huntington’s Disease, Others), CNS Trauma, CNS Cancer, Infectious Diseases, Others); Region—Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025–2033
Central nervous system therapeutic market was valued at US$ 129.38 billion in 2024 and is projected to hit the market valuation of US$ 235.87 billion by 2033 at a CAGR of 6.90% during the forecast period 2025–2033. Read More
We Are Trusted By These Great Companies!
Last Updated: 26-Aug-2025 | Format: | Report ID: AA08251475